Nexam Chemical announces placement of new shares through a new share issue
Nexam Chemical Holding AB (publ) (“Nexam Chemical”) today announces a placement of new shares through a directed new share issue (the “New Issue”)
This press release may not be announced, published or distributed, directly or indirectly in the United States, Canada, Hong Kong, Japan, New Zealand, South Africa or Australia.
Nexam Chemical has engaged ABG Sundal Collier AB as bookrunner in a placement of newly issued shares in the New Issue directed towards international institutional investors and qualified investors in Sweden. The purpose of the resolution to issue new shares with deviation from the shareholders’ preferential rights, is primarily to take advantage of an opportunity to raise capital on advantageous terms from new, from a financial perspective, strategically important owners, and thereby promoting Nexam Chemical’s ability to create further value for all shareholders. The proceeds from the new share issue are intended to be used to finance and enabling the continuance of a high rate of expansion and the development of the company, its markets and products.
The price of the new shares will be determined through an accelerated book-building process and the new shares that will be issued in the New Issue will be admitted to trading on NASDAQ OMX First North following their issuance and registration. The book-building will start immediately. The minimum order in the New Issue has been set to the number of shares that equals an aggregated purchase price of at least equivalent of SEK 1,000,000. Pricing and allocation in the New Issue are expected to take place before beginning of trading on NASDAQ OMX First North at 09.00 CET on March 14, 2014. The total amount of shares in the New Issue will be determined in the book-building process.
The New Issue is subject to, inter alia, that the Board of Directors of Nexam Chemical resolves on issuance of new shares following close of the book-building process, pursuant to the authorization given by the general meeting on March 20, 2013.
The publication or distribution of this press release may in certain jurisdictions be subject to restriction by law, and persons in the jurisdictions where this press release has been published or distributed should inform themselves of and follow such legal restrictions. This press release does not contain or constitute an invitation or offer to acquire, subscribe to or otherwise trade with shares, subscription rights or other securities in Nexam Chemical.
This press release may not be made public, published or distributed, either directly or indirectly in the United States, Canada, Hong Kong, Japan, New Zealand, South Africa, Australia or any other country where such procedures are subject in full or in part to legal restrictions. Nor may the information in this press release be communicated, reproduced or presented in any way that is in conflict with such restrictions. Failure to follow this instruction may involve a breach of the United States Securities Act from 1933 (“Securities Act”) or applicable laws in other jurisdictions.
This press release may contain forward-looking statements. When used in this press release, words such as “evaluate”, “expect” and “intend” are intended to identify forward-looking statements. They may involve risks and uncertainties, including product demand and market acceptance, the effect of economic conditions, the impact of competitive products and pricing, foreign currency exchange rates and other risks. These forward-looking statements reflect the views of the management as of the date made with respect to future events and are subject to risks and uncertainties. All of these forward-looking statements are based on estimates and assumptions made by the management and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results or experience could differ materially from the forward-looking statements. Nexam Chemical disclaims any intention or obligation to update these forward-looking statements.